MedPath

Arkansas State University

Arkansas State University logo
🇺🇸United States
Ownership
Private
Established
1909-01-01
Employees
251
Market Cap
-
Website
http://www.astate.edu

Effectiveness of Two Types of Treatment in Restoring Muscle After Hip or Knee Surgery

Phase 2
Completed
Conditions
Hip Fracture
Osteoarthritis
Femur Head Necrosis
Interventions
Drug: Placebo
Drug: Essential amino acid supplement
First Posted Date
2006-10-29
Last Posted Date
2014-06-02
Lead Sponsor
University of Arkansas
Target Recruit Count
40
Registration Number
NCT00393848
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Using PET-CT to Target and Validate Low-frequency TMS as Treatment for Tinnitus

Not Applicable
Completed
Conditions
Tinnitus
Interventions
Device: Repetitive Transcranial Magnetic Stimulation (rTMS)
First Posted Date
2006-05-24
Last Posted Date
2015-05-04
Lead Sponsor
University of Arkansas
Target Recruit Count
5
Registration Number
NCT00329524
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Bevacizumab and Erlotinib in Inoperable and Metastatic Hepatocellular Carcinoma

Phase 2
Completed
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2006-02-06
Last Posted Date
2011-07-15
Lead Sponsor
University of Arkansas
Target Recruit Count
21
Registration Number
NCT00287222
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

🇺🇸

Kansas University Medical Center, Kansas City, Kansas, United States

Near-Continuous, Noninvasive Blood Pressure Monitoring to Improve Outcomes in Pediatric Transport

Not Applicable
Terminated
Conditions
Pediatric Patients With SIRS (Systemic Inflammatory Response Syndrome)
Interventions
Device: Standard of care blood pressure monitoring
Device: Continuous blood pressure monitoring using (Dinamap) standard oscillometric blood pressure device
First Posted Date
2006-01-19
Last Posted Date
2012-04-30
Lead Sponsor
University of Arkansas
Target Recruit Count
94
Registration Number
NCT00279591
Locations
🇺🇸

Arkansas Children's Hospital, Little Rock, Arkansas, United States

Disulfiram for Treating Cocaine Dependence in Individuals Maintained on Methadone

Phase 2
Completed
Conditions
Cocaine-Related Disorders
Opioid-Related Disorders
Interventions
First Posted Date
2005-09-22
Last Posted Date
2012-01-31
Lead Sponsor
University of Arkansas
Target Recruit Count
158
Registration Number
NCT00218608
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Primary Systemic Therapy in Operable/Locally Advanced Breast Cancer

Phase 2
Completed
Conditions
Breast Cancer
Interventions
First Posted Date
2005-09-20
Last Posted Date
2016-05-11
Lead Sponsor
University of Arkansas
Target Recruit Count
40
Registration Number
NCT00203502
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

Study of Velcade® and Bone Formation in Patients With Relapsed/Refractory Multiple Myeloma

Phase 2
Terminated
Conditions
Multiple Myeloma
Interventions
Drug: VELCADE™
First Posted Date
2005-08-10
Last Posted Date
2012-04-26
Lead Sponsor
University of Arkansas
Target Recruit Count
18
Registration Number
NCT00128921
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UARK 2003-25: A Study of Intravenous (IV) Busulfan (Busulfex®) in Multiple Myeloma Patients

Phase 1
Terminated
Conditions
Multiple Myeloma
Interventions
First Posted Date
2005-06-13
Last Posted Date
2017-10-16
Lead Sponsor
University of Arkansas
Target Recruit Count
14
Registration Number
NCT00113919
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

🇺🇸

University of Arkansas for Medical Sciences, Myeloma Institute for Research and Therapy, Little Rock, Arkansas, United States

UARK 2003-41: A Study of High-Dose Density Therapy in Patients With Multiple Myeloma

Phase 2
Completed
Conditions
Multiple Myeloma
First Posted Date
2005-06-13
Last Posted Date
2011-09-02
Lead Sponsor
University of Arkansas
Target Recruit Count
140
Registration Number
NCT00113932
Locations
🇺🇸

University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States

UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients

Phase 3
Completed
Conditions
Multiple Myeloma
Interventions
First Posted Date
2005-05-25
Last Posted Date
2015-10-06
Lead Sponsor
University of Arkansas
Target Recruit Count
180
Registration Number
NCT00111748
Locations
🇺🇸

University of Arkansas for Medical sciences, Little Rock, Arkansas, United States

© Copyright 2025. All Rights Reserved by MedPath